COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 35: Line 35:
* [[User:Aisha Adigun|Aisha Adigun, M.D.]]
* [[User:Aisha Adigun|Aisha Adigun, M.D.]]
* [[User:Bosky Soni|Bosky Soni, M.D., MPH]]
* [[User:Bosky Soni|Bosky Soni, M.D., MPH]]
* [[User:Neepa Shah|Neepa Shah, M.D]]


'''Hematologic disorders of COVID-19 Team Members'''
'''Hematologic disorders of COVID-19 Team Members'''

Revision as of 15:11, 11 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:

Cardiovascular Disorders of COVID-19 Team Members

Dermatologic Disorders of COVID-19 Team Members

Frequently Asked Inpatient Questions Team Members

Frequently Asked Outpatient Questions Team Members

Hematologic disorders of COVID-19 Team Members

  • Ifrah Fatima

Nephrologic Disorders of COVID-19 Team Members

Neurologic Disorders and COVID-19 Team Members

Ongoing Clinical Trials of COVID-19 Team Members


Pulmonary Disorders and COVID-19 Team Members

  • Rana Aljebzi
  • Ayesha Farheen Javid


Radiologic Manifestations of COVID-19 Team Members


Other Team Members